六种动脉粥样硬化标志物的研究进展

[1] 载脂蛋白E基因敲除小鼠血脂及心肌酶学的测定及意义 [J]. 现代生物医学进展, 2010, 10 (04) : 639 - 641

[2] 细胞流式术检测同型半胱氨酸诱导血管平滑肌细胞凋亡的研究 [J]. 滨州医学院学报, 2009, 32 (06) : 417 - 419

[3] 血清载脂蛋白A-1、载脂蛋白B和脂蛋白(a)与冠心病相关性的临床分析 [J]. 安徽医科大学学报, 2009, 44 (03) : 395 - 398

[4] Plasma Lp-PLA2 in Acute Coronary Syndrome: Association with Major Adverse Cardiac Events in a Community-Based Cohort[J] . Li,Yu,Gu.Postgraduate Medicine . 2010 (4)

[5] C-reactive protein: Risk factor, biomarker and/or therapeutic target?[J] . Jacques Genest.Canadian Journal of Cardiology . 2010

[6] Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review[J] . Marianne Benn.Atherosclerosis . 2009 (1)

[7] Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study[J] . Matthew J McQueen,Steven Hawken,Xingyu Wang,Stephanie Ounpuu,Allan Sniderman,Jeffrey Probstfield,Krisela Steyn,John E Sanderson,Mohammad Hasani,Emilia Volkova,Khawar Kazmi,Salim Yusuf.The Lancet . 2008 (9634)

[8] Review of the Evidence for the Clinical Utility of Lipoprotein-Associated Phospholipase A 2 as a Cardiovascular Risk Marker[J] . Marshall A. Corson,Peter H. Jones,Michael H. Davidson.The American Journal of Cardiology . 2008 (12)

[9] Common Genetic Polymorphisms and Haplotypes of Fibrinogen Alpha, Beta, and Gamma Chains Affect Fibrinogen Levels and the Response to Proinflammatory Stimulation in Myocardial Infarction Survivors[J] . Bénédicte Jacquemin,Charalambos Antoniades,Fredrik Nyberg,Estel Plana,Martina Müller,Sonja Greven,Veikko Salomaa,Jordi Sunyer,Tom Bellander,Alexandros-Georgios Chalamandaris,Ricardo Pistelli,Wolfgang Koenig,Annette Peters.Journal of the American College of Cardiology . 2008 (11)

[10] Estimating LDL ApoB: Infomania or Clinical Advance?[J] . Burnett,John R,Watts,Gerald F.Clinical Chemistry . 2008 (5)

[1] 载脂蛋白E基因敲除小鼠血脂及心肌酶学的测定及意义 [J]. 现代生物医学进展, 2010, 10 (04) : 639 - 641

[2] 细胞流式术检测同型半胱氨酸诱导血管平滑肌细胞凋亡的研究 [J]. 滨州医学院学报, 2009, 32 (06) : 417 - 419

[3] 血清载脂蛋白A-1、载脂蛋白B和脂蛋白(a)与冠心病相关性的临床分析 [J]. 安徽医科大学学报, 2009, 44 (03) : 395 - 398

[4] Plasma Lp-PLA2 in Acute Coronary Syndrome: Association with Major Adverse Cardiac Events in a Community-Based Cohort[J] . Li,Yu,Gu.Postgraduate Medicine . 2010 (4)

[5] C-reactive protein: Risk factor, biomarker and/or therapeutic target?[J] . Jacques Genest.Canadian Journal of Cardiology . 2010

[6] Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review[J] . Marianne Benn.Atherosclerosis . 2009 (1)

[7] Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study[J] . Matthew J McQueen,Steven Hawken,Xingyu Wang,Stephanie Ounpuu,Allan Sniderman,Jeffrey Probstfield,Krisela Steyn,John E Sanderson,Mohammad Hasani,Emilia Volkova,Khawar Kazmi,Salim Yusuf.The Lancet . 2008 (9634)

[8] Review of the Evidence for the Clinical Utility of Lipoprotein-Associated Phospholipase A 2 as a Cardiovascular Risk Marker[J] . Marshall A. Corson,Peter H. Jones,Michael H. Davidson.The American Journal of Cardiology . 2008 (12)

[9] Common Genetic Polymorphisms and Haplotypes of Fibrinogen Alpha, Beta, and Gamma Chains Affect Fibrinogen Levels and the Response to Proinflammatory Stimulation in Myocardial Infarction Survivors[J] . Bénédicte Jacquemin,Charalambos Antoniades,Fredrik Nyberg,Estel Plana,Martina Müller,Sonja Greven,Veikko Salomaa,Jordi Sunyer,Tom Bellander,Alexandros-Georgios Chalamandaris,Ricardo Pistelli,Wolfgang Koenig,Annette Peters.Journal of the American College of Cardiology . 2008 (11)

[10] Estimating LDL ApoB: Infomania or Clinical Advance?[J] . Burnett,John R,Watts,Gerald F.Clinical Chemistry . 2008 (5)